160
Participants
Start Date
August 31, 2007
Primary Completion Date
August 31, 2025
Study Completion Date
August 31, 2026
Proleukin and Dacarbazine
"IL-2 (Proleukin), injected just under the skin, at a dose of 12 million units on days 1-4 for each of the six months of therapy.~Dacarbazine, administered as an IV infusion through a freely flowing IV, at a dose of 750 mg, repeated every four weeks."
James Graham Brown Cancer Center, Louisville
James Graham Brown Cancer Center
OTHER
University of Louisville
OTHER